Arkolith/Insider Trading/BLTE/Form 4

Mata Nathan L.

Chief Scientific OfficerBELITE BIO, INC (BLTE) · full profile →Form 4 · filed Apr 27, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$160K
Net Open-Market Flow
-$160K
Transactions
6
6 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 24, 2026Sell(S)74$157.86$12K10K
Apr 24, 2026Sell(S)190$158.65$30K9K
Apr 24, 2026Sell(S)375$159.46$60K9K
Apr 24, 2026Sell(S)330$160.40$53K9K
Apr 24, 2026Sell(S)28$161.22$5K9K
Apr 24, 2026Sell(S)3$162.53$4889K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-182316) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML